Viewing Study NCT07325435

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-06-21 @ 1:17 AM
Study NCT ID: NCT07325435
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2026-01-08
First Post: 2025-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
Sponsor: MaryAnn Banerji
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes (T2DM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Beta Cell Function View
None Type 2 diabetes View
None Black African American View
None Diabetes metabolism View
None GLP-1 receptor Agonist View
None SGLT-2 inhibitor View
None medication effects in Type 2 Diabetes View